Recent studies (1-3) have provided evidence that a humoral substance secreted by the kidney leads to the hypersecretion of aldosterone which occurs after acute hemorrhage, during chronic Na depletion and during chronic thoracic caval constriction. In subsequent preliminary reports, it has been demonstrated that an aldosterone-stimulating factor is present only in the renin fraction of kidney extracts (4), and that infusions of both renin and angiotensin II result in increased aldosterone output in the dog (5). These findings are consistent with the work of several groups of investigators (6-12), recently summarized by Tobian (13, 14) , which suggests that the reninangiotensin II system plays an important role in the regulation of aldosterone secretion.
Recent studies (1) (2) (3) have provided evidence that a humoral substance secreted by the kidney leads to the hypersecretion of aldosterone which occurs after acute hemorrhage, during chronic Na depletion and during chronic thoracic caval constriction. In subsequent preliminary reports, it has been demonstrated that an aldosterone-stimulating factor is present only in the renin fraction of kidney extracts (4) , and that infusions of both renin and angiotensin II result in increased aldosterone output in the dog (5) . These findings are consistent with the work of several groups of investigators (6) (7) (8) (9) (10) (11) (12) , recently summarized by Tobian (13, 14) , which suggests that the reninangiotensin II system plays an important role in the regulation of aldosterone secretion.
The present series of experiments was designed to test the hypothesis that aldosterone secretion is regulated by the renin-angiotensin II system. In the first two experiments the effects of infusions of renin and of synthetic angiotensin II on the pattern of steroid secretion in dogs were studied at several dosage levels; at the smallest dosage level, angiotensin II was infused at a rate too low to affect arterial blood pressure. To determine whether the steroidogenic effects of these agents are dependent upon ACTH release, all experiments were performed in hypophysectomized animals. In the third experiment, aldosterone and corticosterone secretion rates were determined in conscious, unstressed dogs with experimental benign and malignant renal hypertension, and the relationship between the renin content of the hypertensive kidney and aldosterone output was examined.
MATERIALS AND METHODS
In Experiment I, six 16 to 20 kg mongrel dogs were used to study the effects of renin on steroid secretion.
* The present experimental data were presented, in preliminary form, at the meeting of the Federation of the Societies for Experimental Biology in April, 1961. Each animal was anesthetized with Na pentobarbital after which hypophysectomy (transbuccal approach), bilateral nephrectomy, and right adrenolumbar vein cannulation were performed. Two hours after hypophysectomy, and approximately 1 hour after nephrectomy, two groups of control samples of adrenal venous blood were collected at 30-minute intervals. All blood collected in these experiments was replaced immediately by homologous transfusion. In one animal, 5 dog units of renin,' prepared from dog kidney by the method of Haas and Goldblatt (16) , was injected into a foreleg vein; immediately after the injection an infusion of renin was begun at a rate of 0.1 U per kg per minute and continued over the following 40 minutes. In the remaining 5 dogs exactly the same procedure was followed, but a smaller amount of renin (2.2 U as a single initial injection, followed by an infusion of 0.03 U per kg per minute) was given. At least four 10-ml samples of adrenal effluent were collected from 20 to 40 minutes after the onset of the renin infusion. In 5 of the 6 dogs, additional collections of adrenal venous blood were made 30 to 40 minutes after completion of the renin infusion.
In Experiment II the effects of angiotensin II were studied in twenty 15 to 20 kg animals. The dogs were prepared as in Experiment I, except that nephrectomy was performed only in the first 4 and the last 3 dogs of this group. After control collections of adrenal venous blood, angiotensin II in 5 per cent dextrose (valine-5-hypertensin II, Ciba) was infused at different dosage levels. In the first 4 dogs, 20 ,Ag of angiotensin II was injected rapidly into a foreleg vein and was followed by an infusion at a rate of 0. 25 Iug per kg per minute. In 4 of the simple-hypophysectomized2 animals, 4 .0 gg of angiotensin II was given as an initial injection and was followed by an infusion at a rate of 0.05 ltg per kg per minute. The remaining 9 simple-hypophysectomized dogs were given no initial injection of angiotensin II and received only infusions at rates of 0.008 to 0.025 ltg per kg per minute. The rate of infusion in each dog was slightly less than that which caused the minimal detectable rise 1 As defined by Goldblatt, Katz, Lewis and Richardson, 1 dog U of renin is that amount which, when injected into a trained, unanesthetized, 10 to 20 kg dog, results in a maximal increase in mean arterial pressure of 30 mm Hg within 3 minutes after the time of injection (15) . 2 The "simple-hypophysectomized animal" refers to the dog in which the anterior pituitary has been removed and no other physiological alteration has been made. 2026 in mean arterial pressure. In addition, angiotensin II infusions at rates of 0.008 to 0.013 ,lg per kg per minute were given to 3 Na-depleted hypophysectomized-nephrectomized dogs; severe Na depletion in these dogs had been achieved by maintenance on a Na-free diet for 2 weeks, during which time each of the animals had received two injections of 2 ml meralluride sodium (Mercuhydrin) intramuscularly. In each of the 20 dogs, at least 4 samples of adrenal effluent were collected 20 to 40 minutes after the beginning of the angiotensin II infusion. In 2 of the animals which received the largest dose and 2 of the animals which were given the intermediate dose of angiotensin II, further collections of adrenal effluent were made 20 to 30 minutes after the completion of the angiotensin II infusion.
In both Experiments I and II, aortic blood pressures were measured by means of indwelling polyethylene catheters and Statham strain gage transducers and recorded continuously on a Sanborn recorder. Aldosterone and corticosterone secretion rates were determined by methods described previously (17) , with the double isotope derivative technique of Kliman and Peterson (18) . Silber-Porter chromogens were measured by a modification of the technique described by Peterson, Karrer and Guerra (19) .
In Experiment III, 15 trained 16 to 20 kg mongrel dogs were used. All animals received (by force feeding when necessary) a synthetic diet containing 60 mEq Na and 18 mEq K per day throughout the period of study. Control blood pressures were measured in the trained, unanesthetized animals by direct femoral arterial puncture with a 20 gage needle connected to a Statham strain gage transducer, and mean arterial pressures were determined and recorded by a Sanborn recording system. After control blood pressure measurements over a 1 to 3 week period, a Goldblatt clamp was placed on the left renal artery of each dog, by the technique of Goldblatt (20) . Five to 10 days after left renal arterial constriction a similar clamp was placed on the right renal artery. In the last 6 dogs of the group, in an attempt to produce the experimental malignant hypertensive syndrome, the degree of renal arterial constriction was increased to such an extent that the pulse in the renal artery distal to the Goldblatt clamp was approximately one-fourth of that proximal to the clamp, as determined by digital palpation. In 7 of the 15 animals, serum Na and K determinations were performed by flame photometry both during the control period and 4 to 14 days after application of the second Goldblatt clamp. At intervals varying from 3 days to 3 weeks after the second Goldblatt clamp had been applied, a polyvinyl catheter was placed in the right adrenolumbar vein of each animal under sterile conditions, and three 10-ml samples of adrenal venous blood were obtained.
In 9 of these 15 animals, collections of adrenal effluent were made daily for periods of 3 to 13 days from the conscious, unstressed animal via the chronic indwelling adrenal venous catheter. In one of the animals, the right adrenal venous catheter was removed after 2 weeks of daily collections. In this dog blood pressure measurements were continued over the following 8 (22, 23) , aldosterone and corticosterone secretion rates for each dog were determined only on those days on which the hematocrit approximated the control level.
Four of the animals with benign renal hypertension were anesthetized with Na pentobarbital at intervals of 15, 16, 60 , and 90 days, respectively, after the application of the second Goldblatt clamp, and the kidneys were rapidly removed and frozen at -200 C; care was taken to avoid blood loss during removal of the kidneys. The kidneys were also removed from 4 of the dogs with malignant hypertension as soon as possible after the death of the animal; the interval between application of the second Goldblatt clamp and removal of the kidneys varied from 7 to 17 days in these animals. At intervals of 2 to 6 months after freezing, the kidneys were thawed in a water bath at room temperature, and renin was extracted by a modification of the technique of Haas and Goldblatt (16) . The modification consisted in acidifying the extract to pH 2.75 (instead of pH 2.60), as this was the pH level at which the maximal yield of renin was obtained from normal dog kidneys in our laboratory. The pH was determined with a model 76 Beckman expanded scale pH meter. Renin extractions of both kidneys of one benign and one malignant hypertensive dog were always performed simultaneously. Assays of the potency of each sample of renin were performed in duplicate or triplicate, with a modification of the technique described by Goldblatt and colleagues (15) . The modification consisted in measuring arterial blood pressure by direct femoral arterial puncture with a 20 gage needle attached to a Statham strain gage transducer, and determining mean arterial pressure on a Sanborn recording system.
RESULTS
Effects of renin on steroid secretion in hypophy-
sectomtized-nephrectomized dogs
In each animal the control aldosterone, corticosterone and Porter-Silber chromogen secretion rates were in the range previously observed in hypophysectomized-nephrectomized dogs (1, 3) (Table I, see Figure 1 ). Injection of 5 dog U of renin followed by infusion of renin at a rate of 0.1 U per kg per minute (Figure 1 ) re- suited in a striking increase in secretion rates of each of the steroids studied; the relative increases in aldosterone (4-fold) and corticosterone output (5-fold) were greater than the increment in Porter-Silber chromogen produc- (Figure 2 and Dogs 1-4 of Table II ). The average corticosterone secretion rate showed a 33-fold rise ( Figure 2 and Table II ). The average Porter-Silber chromogen production increased 375 per cent (Table II) . Although the absolute increase was not so great for aldosterone as for corticosterone, the average level of aldosterone secretion during angiotensin II infusion was essentially the same as that observed in normal dogs stressed by laparotomy (17) rate of each of the steroids (160 per cent for aldosterone, 142 per cent for corticosterone, 50 per cent for Porter-Silber chromogens) was less than that observed after the larger dose of angiotensin II was given to nephrectomized-hypophysectomized dogs; however, the reduction in increment in aldosterone secretion was not nearly so great as the decrease in increment in corticosterone output, and was also less than the reduction in increment in Porter-Silber chromogen production ( Table II) . The increases in steroid secretion rates during administration of angiotensin II at this dosage level were comparable in magnitude with the increases observed during infusion of renin at the rate described above. In the two animals in which postinfusion studies were made, secretion rates of aldosterone and corticosterone had decreased but had not returned to control levels within 20 minutes after completion of the angiotensin II infusion. Infusion of angiotensin II at this dosage level resulted in increases in mean arterial pressure in all animals, but the initial increases were not so marked as during administration of the larger dose to hypophysectomizednephrectomized dogs, and the elevations of arterial pressure were not maintained throughout the period of study (Dogs 5-8, Table II) . Adrenal blood flow showed no consistent changes during the angiotensin II infusion. C. Low dosage level; infusion of angiotensin II at 0.008 to 0.025 sg per kg per minute. When angiotensin II was infused into 9 simple-hypophysectomized dogs at a rate slightly less than that which caused the minimal detectable increase in mean arterial pressure (no initial injection of angiotensin II was given) variable results were obtained (Dogs 9-17, Table II . Figure 3 ). On two of the four days on which the aldosterone output exceeded 0.010
Mg per minute, the simultaneous corticosterone secretion rate was greater than 1.80 Mg per minute ( Figure 3) ; these very high values for corticosterone output probably reflect a greater than basal rate of release of ACTH. It is suggested that the slightly higher aldosterone secretion rates on these days were secondary to increased ACTH release and did not result from increased secretion of the renal aldosterone-stimulating substance. The rate of corticosterone secretion during infusion of angiotensin II was considerably less than 1.80 Mg per minute during aldosterone secretion rates of the magnitude (0.010 to 0.015 Mug per minute) observed here.
For the group of 7 dogs (9-15, Tables III, IV , and V, with the exception of Dog X which was an animal with benign renal hypertension of 2 months' duration, on which steroid secretion rates were not determined.
renin yield per gram of tissue and the total weight of both kidneys) of the two kidneys of the dogs with malignant renal hypertension was 160 dog U (range, 125 to 185), while the average renin content of the two kidneys of the dogs with benign renal hypertension was 29 dog U, (range, 19 to 38; Table VI) . The difference between the benign and malignant hypertensive groups is highly significant statistically (t, 7.37; p < 0.01). The average renin content of the kidneys of the dogs with benign hypertension was also greater than the renin content of the kidneys of normal dogs which had been maintained on the same synthetic diet and electrolyte intake for 5 to 10 days before the kidneys were removed (Table VI) , but the difference was of borderline statistical significance (t, 2.66; 0.05 > p > 0.02).
DISCUSSION
The concept that aldosterone secretion is regulated by the renin-angiotensin system is derived from the findings of many investigators (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . This hypothesis was suggested by the indirect evidence that renin injections cause hypertrophy of the adrenal zona glomerulosa (6) and that the degree of granulation of the juxtaglomerular (JG) cells is directly correlated both with the amount of extractable renin in the kidney (9, 10, 13) and with the width of the adrenal zona glomerulosa (7, 8, 14) . It has recently received strong support from the direct demonstration that an aldosterone-stimulating factor is secreted by the kidney (1-3) and that aldosterone-stimulating activity is confined to the renin fraction of crude kidney extracts (4). Tobian, after clearly summarizing the findings of many investigators in this field, (13, 14) , has further postulated that the cells that produce renin, the JG cells (25, 26) , located in the media of the renal afferent arterioles, act as baroreceptors responsive to the degree of filling of these vessels (13, 27) . On the basis of this hypothesis, the JG cells would respond to decreased stretch of the renal afferent arterioles by an increase in renin secretion with a consequent augmentation of aldosterone output, and vice versa. Thus, the renin-angiotensin system, which appears to serve as a homeostatic mechanism in the maintenance of arterial blood pressure (28) , could also perform a homeostatic function in the control of aldosterone secretion. The present experimental results are consistent with this concept.
The finding that infusion of very small quantities of renin increased the secretion rate of aldosterone in the hypophysectomized-nephrectomized dog adds support to the theory that the reninangiotensin system performs a physiological role in the control of aldosterone secretion. Although renin infusion in the present experiments resulted in increased production of corticosterone and Porter-Silber chromogens as well as aldosterone, the pattern of response was quite different from that seen during infusion of ACTH (29) . Renin infusion increased the rate of aldosterone secretion to levels similar to those observed during infusion of ACTH in acutely hypophysectomized dogs (29) and after the stress of laparotomy in normal dogs (17) . In marked contrast to these findings, the values during renin infusion for corticosterone and Porter-Silber chromogen output were approximately 10 and 2 per cent, respectively, of the values observed in normal dogs stressed by laparotomy (17, 24) and in hypophysectomized dogs given ACTH infusions (29) . In fact, the secretion rates during renin infusion for corticosterone-and Porter-Silber chromogens are essentially the same as the values observed in conscious, unstressed normal dogs with chronic adrenal venous catheters (24) . Since it has been demonstrated (24) in studies on conscious dogs that corticosterone and Porter-Silber chromogen secretion rates may be low in the presence of a very high rate of aldosterone production (and presumably in the presence of increased quantities of the aldosterone-stimulating factor produced by the kidney), the results from the present renin infusion experiments are consistent with the concept that the renal aldosterone-stimulating factor is identical with renin.
The demonstration that angiotensin II also increases aldosterone output is in agreement with the previously reported findings of both Biron and associates (12) and Laragh, Angers, Kelly and Lieberman (11) that angiotensin II infusion consistently increases aldosterone production in man. The present results, obtained from hypophysectomized dogs, clearly demonstrate that angiotensin II increases aldosterone secretion by a non-ACTH mechanism, a finding that was suggested by the pattern of steroid secretion observed in the earlier studies in man (11, 12) . The very marked increase in corticosterone observed in two of the four dogs which received the largest dose of angiotensin II would at first appear inconsistent with the hypothesis that the renin-angiotensin system regulates aldosterone secretion, since a maximal rate of aldosterone secretion is frequently observed in the presence of a very low basal corticosterone output in experimental secondary hyperaldosteronism (24) . However, the rate of infusion of angiotensin II at the highest dosage level almost certainly exceeds the rate at which angiotensin II is released under physiological conditions (30) . It is entirely possible that very great increases in activity of the renin-angiotensin system may cause appreciable increases in corticosterone as well as aldosterone. Indeed, one recent study (3) has demonstrated that nephrectomy of both hypophysectomized caval and hypophysectomized Nadepleted dogs resulted in a marked decrease in corticosterone as well as aldosterone secretion, and that infusion of extracts of renal tissue from dogs with secondary hyperaldosteronism increased both corticosterone and aldosterone production.
The finding that the intermediate dosage of angiotensin II (the pressor effect of which was roughly equivalent to the pressor effect of the renin used in Experiment I) caused essentially the same qualitative changes in steroid secretion as did the renin infusion, suggests that renin exerts its effect on aldosterone secretion via angiotensin II. It is noteworthy that the increments in corticosterone (2-to 6-fold) and Porter-Silber chromogen (0-to 4-fold) production observed during infusion of the intermediate dosage of angiotensin II are roughly comparable with the increments in cortisol and tetrahydrocortisol excretion (2-to 3-fold) noted by Genest (31) during the infusion of angiotensin II in man at rates that caused moderate, sustained elevations of blood pressure. As pointed out by this investigator, increases in this magnitude of 17-hydroxycorticoids and of corticosterone are "small in terms of physiological significance" in comparison with the concomitant increases in aldosterone output that occurred during the angiotensin II infusion.
The results obtained after the infusion of 0.008 to 0.025 jug per kg per minute of angiotensin II indicate that the minimal effective steroid-stimulating dose of angiotensin II may vary appreciably from animal to animal. Responses in aldosterone secretion occurred in the absence of an increase in blood pressure but never without a slight concomitant increase in corticosterone output. It has been reported by Genest (31) , in regard to the response to angiotensin II infusions in man, that the minimal effective dose for blood pressure response exceeds the dose necessary to produce a measurable increase in aldosterone production. Although the present experimental data suggest that this situation may prevail in the dog, the present findings, obtained from anesthetized dogs which were hypophysectomized or hypophysectomized and nephrectomized, cannot be extrapolated with certainty to the conscious intact animal. Indeed, Goldblatt (32) has pointed out that the blood pressure response to renin in the barbiturate-anesthetized dog is markedly decreased as compared with the blood pressure response in normal conscious dogs.
Since the results from infusion of renin and angiotensin II support the hypothesis that aldosterone secretion is regulated by the renin-angiotensin system, the question arises as to the nature of the stimulus to renin production. Goldblatt, in his classic series of studies (32) showed that the renin content of the kidneys increased after bilateral renal arterial constriction; it was then postulated that diminished renal blood flow (RBF) was the immediate stimulus to renin production. Corcoran and Page (33) subsequently showed that diminished renal blood flow was not invariably present in animals with experimental renal hypertension, and suggested that diminished pulse pressure in the renal arterioles provided the stimulus to renin production in these circumstances. However, later evidence (34) indicated that in animals with experimental renal hypertension secondary to encapsulation of the kidney, the intrarenal pulse pressure was increased rather than decreased. More recently Tobian (13) has pointed out that decreased stretch in the renal afferent arterioles (resulting in the clamped kidney from decreased renal arteriolar pressure, and in the encapsulated kidney from increased extrinsic pressure from the tissues surrounding the afferent arteriole) may be a common factor to both types of renal hypertension, and has postulated that decreased stretch provides the stimulus to increased renin production by the juxtaglomerular cells in both situations. This suggestion appears consistent with available data.
In the present experiments aldosterone secretion was increased above the normal range in only one of eight dogs with benign renal hypertension. This finding appears inconsistent with the concept that aldosterone secretion is regulated by the renin-angiotensin system, since earlier experiments indicated that increased production of renin is present in the majority of animals with renal hypertension during the first 3 months after bilateral renal arterial constriction (16. 32, 35) . Two explanations for this apparent inconsistency present themselves. In the first place, it is possible that increased renin secretion does not occur in the benign phase of experimental renal hypertension. Although increased renin content of the kidneys has appeared consistently to be present in previous studies of benign experimental and human essential hypertension (16, 32) , increased renin secretion by the kidney in these situations has not been conclusively demonstrated in either man or dog (13, 36, 37) . In the present dogs with benign experimental renal hypertension, the renin content of the kidneys, although greater that that found in normal dogs, was considerably lower than that observed in malignant renal hypertension. It is possible in benign experimental hypertension either that the hypertension is caused by increased sensitivity to small amounts of renin or that the hypertension is not solely dependent upon the renin-angiotensin system. In the second place, it is possible that the amount of renin secreted by the dogs with benign experimental hypertension, although increased to a level adequate to produce and maintain hypertension, is not adequate to cause hypersecretion of aldosterone. This latter alternative seems less likely in view of the previously cited findings of Genest (31) that angiotensin II infusion at a rate too low to elicit a blood pressure response augmented aldosterone output in man.
In the present study the dog in the benign hypertensive group in which the greatest rate of aldosterone production was noted (Dog 6 of Tables III and V) deserves special comment. This dog, alone among the animals in the benign group, appeared clinically to be developing malignant hypertension; beginning 3 days after the second Goldblatt clamp was placed (one day before the chronic adrenal catheter was inserted), he showed progressive lethargy, anorexia (but no vomiting despite forced feeding of diet) and weight loss. These symptoms persisted for 7 to 8 days, after which gradual improvement was observed. The symptoms coincided with the period during which hypersecretion of aldosterone was observed in this dog (during laparotomy and on Days 1-7 of Table V ). It appears possible that both the malignant hypertensive symptoms and the hypersecretion of aldosterone were reflections of a marked increase in renin secretion resulting from a very substantial reduction in pressure in, or flow through, the renal afferent arterioles; and that both the symptomatic improvement and the decrease in aldosterone output resulted from the development of collateral renal arterial blood supply with a consequent decrease in renin production. In the present experiments extensive renal collateral vessels were observed within 10 days after application of the second Goldblatt clamp, and earlier studies (38) have demonstrated that renal blood flow may return to normal prehypertensive levels within 2 to 3 weeks after moderately severe constriction of the renal artery of a single explanted kidney.
The finding of consistent increases in aldosterone secretion rate in dogs with malignant hypertension is in agreement with the similar findings in man by Genest (39) , Laragh (40) and Venning (41) , and their co-workers and is entirely consonant with the hypothesis that the renin-angiotensin system performs a major role in the regulation of aldosterone secretion. The majority of reports indicate that renin secretion by the kidneys, as well as renin content of the kidneys, is increased in the malignant phase of both human essential and experimental renal hypertension (13, 30, 35. 42 ). This hypothesis is further supported by the present experimental finding that the renin content of the kidneys of the malignant hypertensive dogs, which exhibited marked hypersecretion of aldosterone, was greatly increased over the renin content in the benign hypertensive dogs in which aldosterone production was only slightly above the normal range.
Since the present experimental data are consistent with the hypothesis that aldosterone secretion is regulated by the renin-angiotensin system, the question arises as to why hypertension is not present in such situations as congestive heart failure, the post-hemorrhagic state, during thoracic inferior vena caval constriction, and during chronic Na depletion-conditions in which hypersecretion of aldosterone is a consistent finding (1, 3, 43) . Increased renin secretion has been reported in congestive heart failure (44) and after hemorrhage (45) ; and hyperplasia and hypergranulation of the juxtaglomerular cells, which provide presumptive evidence of increased renin production (14, 46) , have recently been found after thoracic caval constriction (47) and during chronic Na depletion (9) . The explanation may be that in these situations increased circulating angiotensin II, with a consequent increase in total peripheral resistance, serves to maintain a normal blood pressure. Thus, the renin-angiotensin system may act as a homeostatic mechanism (8, 28) to maintain an adequate flow of blood to vital organs under these circumstances. Recent observations that the blood pressure response to angiotensin II is greatly reduced in the dog during chronic Na depletion or during thoracic caval constriction (48) support this view. Available data therefore appear to be uniformly consistent with the hypothesis that the renin-angiotensin system plays an important role in the regulation of aldosterone production in a variety of circumstances in which hypersecretion of aldosterone is known to occur.
SUMMARY AND CONCLUSIONS
Infusion of renin into hypophysectomizednephrectomized dogs increased the rates of secretion of aldosterone, corticosterone and PorterSilber chromogens by a non-ACTH mechanism. Infusion of synthetic angiotensin II into hypophysectomized-nephrectomized or simple-hypophysectomized dogs (only anterior pituitary removed) likewise augmented the production of each of the steroids measured; a decrease in the rate of infusion of angiotensin II reduced the increment in corticosterone secretion to a far greater extent than the increment in aldosterone secretion. With doses of angiotensin II too small to elicit a blood pressure response, physiologically significant increases in aldosterone secretion were sometimes observed. At this very low dosage level, the increments in corticosterone output were quantitatively slightly greater than those of aldosterone but were at a level which usually has no physiological effect, and no significant changes in Porter-Silber chromogen production occurred. The renin content of the kidneys of dogs with benign renal hypertension was only slightly increased, and aldosterone secretion was within normal limits in these animals. A 10-fold increase in the renin content of the kidneys was observed in dogs with malignant renal hypertension, and aldosterone output was markedly increased, by a non-ACTH mechanism, in this group of dogs. These data are consistent with the concept that the renin-angiotensin II system plays an important physiological role in the regulation of aldosterone secretion.
